Trelagliptin succinate
98%
- Product Code: 124911
CAS:
1029877-94-8
Properties:
This product is for scientific research only
| Molecular Weight: | 475.47 g./mol | Molecular Formula: | C₂₂H₂₆FN₅O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22665720 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Trelagliptin succinate is primarily used in the management of type 2 diabetes mellitus. It functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps regulate blood glucose levels by increasing the activity of incretin hormones. These hormones stimulate insulin release and reduce glucagon secretion, particularly after meals. Its long-acting formulation allows for once-weekly dosing, improving patient adherence and convenience. It is often prescribed as part of a comprehensive treatment plan that includes diet, exercise, and other medications to achieve optimal glycemic control. It is particularly beneficial for patients who require a stable and sustained therapeutic effect with minimal dosing frequency.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿5,800.00 |
+
-
|
| 0.010 | 10-20 days | ฿9,200.00 |
+
-
|
| 0.100 | 10-20 days | ฿64,600.00 |
+
-
|
Trelagliptin succinate
Trelagliptin succinate is primarily used in the management of type 2 diabetes mellitus. It functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps regulate blood glucose levels by increasing the activity of incretin hormones. These hormones stimulate insulin release and reduce glucagon secretion, particularly after meals. Its long-acting formulation allows for once-weekly dosing, improving patient adherence and convenience. It is often prescribed as part of a comprehensive treatment plan that includes diet, exercise, and other medications to achieve optimal glycemic control. It is particularly beneficial for patients who require a stable and sustained therapeutic effect with minimal dosing frequency.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :